HRZN: AI 评分 61/100 — AI 分析 (4月 2026)

Horizon Technology Finance Corporation is a business development company (BDC) specializing in providing secured debt and venture lending to venture capital-backed companies. The company focuses on technology, life science, healthcare, and cleantech industries within the United States.

Key Facts: Price: $4.32 AI Score: 61/100 Sector: Financial Services

公司概况

概要：

Horizon Technology Finance Corporation offers investors access to high-growth, venture capital-backed companies in technology and life sciences through secured debt and venture lending. With a substantial dividend yield of 19.94% and a focus on the U.S. market, HRZN presents a unique income opportunity in alternative investments.

HRZN是做什么的？

Horizon Technology Finance Corporation is a business development company (BDC) founded to capitalize on the unmet financing needs of venture capital-backed companies in the technology, life science, healthcare information and services, and cleantech industries. The company's primary objective is to generate current income and capital appreciation by providing secured debt and venture lending solutions to these rapidly growing businesses. Since its inception, Horizon has focused on building a diversified portfolio of investments across various sub-sectors within its target industries, primarily within the United States. Horizon's evolution has been marked by a consistent strategy of identifying and partnering with innovative companies that possess strong management teams and promising technologies. The firm offers a range of financing options, including term loans, equipment financing, and bridge loans, tailored to meet the specific needs of its portfolio companies. This flexibility allows Horizon to establish long-term relationships and support its clients through various stages of growth. Horizon Technology Finance Corporation operates with the goal of delivering attractive returns to its shareholders through a combination of current income from its debt investments and potential capital gains from equity-related investments.

HRZN的投资论点是什么？

Horizon Technology Finance Corporation presents a notable market position due to its focus on high-growth, venture-backed companies in attractive sectors. The company's substantial 19.94% dividend yield offers a significant income stream for investors seeking yield in a low-interest-rate environment. As venture capital continues to flow into technology, life science, and healthcare, Horizon is well-positioned to capitalize on the demand for debt financing. The company's strategy of providing secured debt reduces risk compared to equity investments in early-stage companies. Growth catalysts include the expansion of venture capital activity and Horizon's ability to deploy capital effectively. The company's expertise in structuring debt deals and managing risk should drive long-term value creation. However, investors should be aware of the company's negative profit margin of -129.6% and P/E ratio of -11.93, indicating the need for careful monitoring of financial performance.

HRZN在哪个行业运营？

Horizon Technology Finance Corporation operates within the asset management industry, specifically focusing on venture debt. The venture debt market has grown significantly as venture capital investments have increased. This growth is driven by the need for early-stage companies to secure financing without diluting equity. The competitive landscape includes other business development companies (BDCs) and specialty finance firms. Horizon differentiates itself through its deep industry expertise and focus on specific sectors like technology and life sciences. These sectors are experiencing rapid growth, creating significant opportunities for venture debt providers.

Asset Management

Financial Services

HRZN有哪些增长机遇？

Expansion of Venture Debt Offerings: The venture debt market is projected to grow as venture capital investments increase. Horizon can capitalize on this trend by expanding its range of debt products and increasing its investment volume. The global venture debt market is estimated to reach billions of dollars, providing ample opportunity for Horizon to grow its market share. This expansion can be realized within the next 3-5 years.
Strategic Partnerships with Venture Capital Firms: Horizon can strengthen its deal flow by forming strategic partnerships with leading venture capital firms. These partnerships would provide access to a pipeline of high-quality investment opportunities and enhance Horizon's ability to deploy capital effectively. Such partnerships can be forged within the next 1-2 years.
Geographic Expansion within the United States: While Horizon currently focuses on the United States, there are opportunities to expand its presence in key technology and life science hubs. By establishing a stronger presence in these regions, Horizon can gain access to a wider range of investment opportunities and build stronger relationships with local venture capital firms. This expansion can be phased in over the next 3-5 years.
Increased Investment in Healthcare Information and Services: The healthcare information and services sector is experiencing rapid growth due to the increasing adoption of digital health technologies. Horizon can capitalize on this trend by increasing its investment in companies that are developing innovative solutions in this space. This sector presents a significant growth opportunity over the next 5-10 years.
Development of New Financing Products: Horizon can develop new financing products tailored to the specific needs of its portfolio companies. These products could include revenue-based financing, equipment leasing, and other innovative financing solutions. By offering a wider range of financing options, Horizon can attract new clients and strengthen its relationships with existing clients. New product development can be an ongoing process, with new offerings introduced every 1-2 years.

Dividend Yield of 19.94% offers a substantial income stream for investors.
Focus on venture capital-backed companies in technology, life science, healthcare, and cleantech industries provides exposure to high-growth sectors.
Secured debt investment strategy mitigates risk compared to equity investments in early-stage companies.
Market Capitalization of $0.31B indicates a relatively small-cap company with potential for growth.
Beta of 0.94 suggests lower volatility compared to the overall market.

HRZN提供哪些产品和服务？

Provide secured debt financing to venture capital-backed companies.
Offer venture lending solutions to development-stage companies.
Invest in technology companies.
Invest in life science companies.
Invest in healthcare information and services companies.
Invest in cleantech companies.
Focus on companies within the United States.

HRZN如何赚钱？

Generate income from interest payments on debt investments.
Realize capital appreciation from equity-related investments.
Manage a diversified portfolio of venture debt investments.
Partner with venture capital firms to source investment opportunities.

Venture capital-backed companies in the technology sector.
Venture capital-backed companies in the life science sector.
Venture capital-backed companies in the healthcare information and services sector.
Venture capital-backed companies in the cleantech sector.

Deep industry expertise in technology, life science, healthcare, and cleantech.
Strong relationships with venture capital firms.
Proven track record of successful venture debt investments.
Ability to structure complex debt deals.

什么因素可能推动HRZN股价上涨？

Ongoing: Continued growth in venture capital investments will drive demand for venture debt.
Ongoing: Strategic partnerships with venture capital firms will enhance deal flow.
Upcoming: Potential acquisitions or mergers could create value for shareholders.
Ongoing: Successful deployment of capital into new investments will drive revenue growth.

HRZN的主要风险是什么？

Potential: Economic downturn could negatively impact the ability of portfolio companies to repay debt.
Potential: Increased competition could reduce interest rates and profitability.
Potential: Changes in interest rates could affect the value of debt investments.
Ongoing: Negative profit margin and P/E ratio indicate financial challenges that need to be addressed.
Ongoing: Reliance on the performance of venture capital-backed companies exposes Horizon to market volatility.

HRZN的核心优势是什么？

High dividend yield of 19.94% attracts income-seeking investors.
Focus on high-growth sectors like technology and life sciences.
Secured debt investment strategy mitigates risk.
Experienced management team with expertise in venture lending.

HRZN的劣势是什么？

Negative profit margin of -129.6% raises concerns about profitability.
Small market capitalization of $0.31B makes the company more volatile.
Reliance on venture capital funding for portfolio companies.
Gross Margin of -78.7%

HRZN有哪些机遇？

Expansion of the venture debt market.
Strategic partnerships with venture capital firms.
Geographic expansion within the United States.
Increased investment in healthcare information and services.

HRZN面临哪些威胁？

Increased competition from other business development companies.
Economic downturn could negatively impact portfolio companies.
Changes in interest rates could affect profitability.
Regulatory changes could impact the venture debt market.

HRZN的竞争对手是谁？

DXYZ — Unknown — (DXYZ)
KOYN — Unknown — (KOYN)
LIEN — Unknown — (LIEN)
MLCI — Unknown — (MLCI)
OACC — Unknown — (OACC)

Key Metrics

Price: $4.32 (+2.01%)
Market Cap: $207.0M
MoonshotScore: 61/100

Company Profile

CEO: Michael Phillip Balkin
Headquarters: Farmington, US
Founded: 2010

AI Insight

Horizon Technology Finance Corporation is a business development company that specializes in lending and investing in development-stage companies. They provide secured debt and venture lending to venture capital-backed companies in technology, life science, healthcare, and cleantech industries within the United States.

常见问题

What does Horizon Technology Finance Corporation do?

Horizon Technology Finance Corporation is a business development company (BDC) that specializes in providing secured debt and venture lending to venture capital-backed companies. The company focuses on high-growth sectors such as technology, life science, healthcare information and services, and cleantech. Horizon's primary goal is to generate current income and capital appreciation by investing in these innovative companies. By offering tailored financing solutions, Horizon supports the growth of its portfolio companies while delivering attractive returns to its shareholders through interest income and potential equity gains.

Is HRZN stock a good buy?

HRZN stock presents a mixed investment profile. The company's high dividend yield of 19.94% is attractive for income-seeking investors. However, the negative profit margin of -129.6% and P/E ratio of -11.93 raise concerns about financial performance. The company's focus on high-growth sectors and secured debt strategy offer potential for long-term value creation. Investors should carefully consider their risk tolerance and conduct thorough due diligence before investing in HRZN, paying close attention to the company's ability to improve profitability and manage risk effectively.

What are the main risks for HRZN?

The main risks for Horizon Technology Finance Corporation include the potential for an economic downturn to negatively impact its portfolio companies, increased competition from other BDCs, and changes in interest rates. The company's negative profit margin and reliance on venture capital funding also pose significant risks. Additionally, regulatory changes and market volatility could affect the company's performance. Investors should be aware of these risks and carefully monitor the company's financial performance and market conditions.